HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanitizer Ingredient Makers Triple Production, Launch Alternative To Meet Demand

Executive Summary

Hand sanitizer shortage spurs thickening agent producer Lubrizol to triple output and Archroma to launch alternative thickening. Separately Clariant started monthly disinfectant production of 2m liters for hospitals and other vital institutions in Bavaria.

You may also be interested in...



'A Black Swan Event’: Perspectives On COVID-19 Pressures On Beauty, Personal Care And Beyond

Cosmetics and personal-care manufacturers are certainly not alone in facing unprecedented challenges during the COVID-19 pandemic. Manufacturers today are uniquely vulnerable to supply chain breakdowns, and the current crisis is a perfect storm for impacts to come and already here.

FDA’s OTC Program Has Changed, But Antiseptic Sector Prepares For More Of The Same

The future of OTC antiseptic products – including antibacterial soaps and sanitizing hand rubs and wipes – came into serious question under FDA monograph actions taken in recent years. Stakeholders agree that Congress’s recently enacted CARES Act promises to transform OTC drug review, but the data requirements and uncertainty surrounding OTC germ-killing ingredients may be quickly reinstated.

Subscription Oral Care Marketer Burst Adjusts Brand Building Program To COVID-19 Shutdowns

The firm says during COVID-19 pandemic, it is waiving the $20 registration fee for its Burst Ambassador program to assist dental hygienists whose offices have closed temporarily, or remain open but put them at risk through close contact with patients and co-workers, potential contamination of saliva and shortage of protective equipment.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149906

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel